BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24882858)

  • 21. Assessment tools in psoriatic arthritis.
    Mease PJ
    J Rheumatol; 2008 Jul; 35(7):1426-30. PubMed ID: 18609738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GRAPPA Trainees Symposium 2013: a report from the GRAPPA 2013 Annual Meeting.
    Szentpetery A; Johnson MA; Ritchlin CT
    J Rheumatol; 2014 Jun; 41(6):1200-5. PubMed ID: 24882852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practical Assessment of Psoriasis Clinical Severity in both Clinical Trials and Clinical Practice Settings: A Report from the GRAPPA 2016 Annual Meeting.
    Merola JF; Gottlieb AB
    J Rheumatol; 2017 May; 44(5):691-692. PubMed ID: 28461528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psoriasis and psoriatic arthritis video project: an update from the GRAPPA 2011 annual meeting.
    Callis Duffin K; Armstrong AW; Mease PJ
    J Rheumatol; 2012 Nov; 39(11):2198-200. PubMed ID: 23118287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring priority research areas in psoriasis and psoriatic arthritis from dermatologists' perspective: a report from the GRAPPA 2011 annual meeting.
    Armstrong AW; Callis Duffin K; Garg A; Gelfand JM; Gottlieb AB; Krueger GG; Qureshi AA; Rosen CF
    J Rheumatol; 2012 Nov; 39(11):2204-10. PubMed ID: 23118289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes research in psoriasis and psoriatic arthritis using large databases and research networks: a report from the GRAPPA 2013 Annual Meeting.
    Armstrong AW; Gelfand JM; Garg A
    J Rheumatol; 2014 Jun; 41(6):1233-6. PubMed ID: 24882860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Care of patients with psoriasis: an audit of U.K. services in secondary care.
    Eedy DJ; Griffiths CE; Chalmers RJ; Ormerod AD; Smith CH; Barker JN; Potter J; Ingham J; Lowe D; Burge S
    Br J Dermatol; 2009 Mar; 160(3):557-64. PubMed ID: 19120330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Report from the International Dermatology Outcome Measures Initiative.
    Perez-Chada LM; Merola JF; Armstrong AW; Garg A; Latella J; Gottlieb AB
    J Investig Dermatol Symp Proc; 2020 Nov; 20(1):S80-S83. PubMed ID: 33099394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Psoriatic Disease Payer Advisory Panel.
    Greb JE; Merola J; Garg A; Latella J; Howard L; Acharya N; Gottlieb AB
    J Drugs Dermatol; 2016 May; 15(5):641-4. PubMed ID: 27168273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a disease severity and responder index for psoriatic arthritis (PsA)--report of the OMERACT 10 PsA special interest group.
    Coates LC; Mumtaz A; Helliwell PS; Mease PJ; Callis-Duffin K; Krueger GG; McHugh NJ; Strand V; Gladman DD; FitzGerald O
    J Rheumatol; 2011 Jul; 38(7):1496-501. PubMed ID: 21724722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient participation in psoriasis and psoriatic arthritis outcome research: a report from the GRAPPA 2013 Annual Meeting.
    de Wit M; Campbell W; FitzGerald O; Gladman DD; Helliwell PS; James J; Lindsay C; MacDonald R; McHugh NJ; Mease PJ; Orbai AM; Palominos P; Parkinson A; Tillett W; Goel N
    J Rheumatol; 2014 Jun; 41(6):1206-11. PubMed ID: 24882853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prologue: 2011 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
    Mease PJ; Gladman DD
    J Rheumatol; 2012 Nov; 39(11):2181-3. PubMed ID: 23118282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A patient decision aid for psoriasis based on current clinical practice guidelines.
    Tan J; Wolfe B
    Arch Dermatol; 2012 Jun; 148(6):718-23. PubMed ID: 22710451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GRAPPA Fellows Symposium Adjacent to the European Academy of Dermatology and Venereology (EADV) Congress, Istanbul, 2013: a meeting report.
    Boehncke WH; Kirby B; Thaci D
    J Rheumatol; 2014 Jun; 41(6):1197-9. PubMed ID: 24882851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes in randomized controlled trials in psoriasis: what has changed over the last 20 years?
    Morsy H; Kamp S; Jemec GB
    J Dermatolog Treat; 2007; 18(5):261-7. PubMed ID: 17917937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice.
    Chalmers RJ
    Dermatol Clin; 2015 Jan; 33(1):57-71. PubMed ID: 25412783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies for improving the quality of care in psoriasis with the use of treatment goals--a report on an implementation meeting.
    Mrowietz U; Kragballe K; Nast A; Reich K
    J Eur Acad Dermatol Venereol; 2011 May; 25 Suppl 3():1-13. PubMed ID: 21470314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Summary of the International Federation of Psoriasis Associations (IFPA) meeting: a report from the GRAPPA 2009 annual meeting.
    Coates LC; Jonckheere CL; Molin S; Mease PJ; Ritchlin CT
    J Rheumatol; 2011 Mar; 38(3):530-9. PubMed ID: 21362781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Composite Measures in Psoriatic Arthritis: a report from the GRAPPA 2009 annual meeting.
    Helliwell PS; Fitzgerald O; Strand CV; Mease PJ
    J Rheumatol; 2011 Mar; 38(3):540-5. PubMed ID: 21362782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practical considerations in future psoriasis therapies.
    Riddle C; Young M; Menter A
    Dermatol Clin; 2004 Oct; 22(4):487-92, x. PubMed ID: 15450344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.